The Impact of Ulcerogenic Drugs on Surgery for the Treatment of Peptic Ulcer Disease

Archives of Surgery

Volumn 126, Issue 5, 1991, Pages 609-612

  Bliss, David W ^a   Stabile, Bruce E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; AGED; ARTICLE; EMERGENCY SURGERY; FEMALE; HUMAN; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; ULCER PERFORATION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMAN; MALE; MIDDLE AGE; PAIN, INTRACTABLE; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; PEPTIC ULCER PERFORATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STEROIDS;

EID: 0025777966     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.1991.01410290085017     Document Type: Article

References (37)

1. Langman MJS. Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use. Gastroenterology. 1989;96:640-646.
2. Graham DY, Smith JL. Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol. 1988;83:1081-1084.
3. Green SB, Gail MH, Byar DP. Steroids and peptic ulcer. N Engl J Med. 1976;294:473-476.
4. Messer J, Sacks HS, Reitman D, Chalmers TC. Corticosteroids do cause peptic ulcer disease. Gastroenterology. 1982;82:1130.
5. Stabile BE, Passaro E Jr. Duodenal ulcer: a disease in evolution. Curr Probl Surg. 1984;21:6-17.
6. McConnell DB, Baba GC, Deveney CW. Changes in surgical treatment of peptic ulcer disease within a Veterans Hospital in the 1970s and the 1980s. Arch Surg. 1989;124:1164-1167.
7. Walt R, Katschinski B, Logan R, Ashley J, Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet. 1986;2:489-492.
8. Fries JF, Miller SR, Spitz PW, Williams CA, Herbert HB, Bloch DA. Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. Gastroenterology. 1989;96:647-655.
9. Collier DStJ, Pain JA. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut. 1985;26:359-363.
10. Guess HA, West R, Strand LM, et al. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol. 1988; 41:35-45.
11. Horowitz J, Kukora JS, Ritchie WP Jr. All perforated ulcers are not alike. Ann Surg. 1989;209:693-697.
12. Kekki M, Samloff IM, Ihamaki T, Varis K, Siurala M. Age and sex-related behavior of gastric acid secretion at the population level. Scand J Gastroenterol. 1982;17:737-743.
13. Farinati F, Cardin F, DiMario F, et al. Gastric ulcer and stomach aging: pathophysiology and clinical implications. Gerontology. 1988;34:297-303.
14. Majumdar AP, Moshier JA, Arlow FL, Luk GD. Biochemical changes in the gastric mucosa after injury in young and aged rats. Biochim Biophys Acta. 1989;21:35-40.
15. Maitra RS, Edgerton EA, Majumdar AP. Gastric secretion during aging in pyloric-ligated rats and effects of pentagastrin. Exp Gerontol. 1988;23: 463-472.
16. Kim SW, Parekh D, Townsend CM Jr, Thompson JC. Effects of aging on duodenal bicarbonate secretion. Ann Surg. 1990;212:332-338.
17. Kolbasa KP, Lancaster C, Olafsson AS, Gilbertson SK, Robert A. Indomethacin-induced gastric antral ulcers in hamsters. Gastroenterology. 1988;95:932-944.
18. Cryer B, Goldschmiedt M, Redfern JS, Feldman M. Comparison of salsalate and aspirin on mucosal injury and gastroduodenal mucosal prostaglandins. Gastroenterology. 1990;99:1616-1621.
19. Matthewson K, Pugh S, Northfield TC. Which peptic ulcer patients bleed? Gut. 1988;20:70-74.
20. Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 1987;28:527-532.
21. Butt JH, Barthel JS, Moore RA. Clinical spectrum of the upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Natural history, symptomatology, and significance. Am J Med. 1988;84(suppl 2A):5-14.
22. Carson JL, Strom BL, Morse ML, et al. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1987;147:1054-1059.
23. Peoples JB. Peptic ulcer disease and the nonsteroidal anti-inflammatory drugs. Am Surg. 1985;51:358-362.
24. Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1986;1:462-464.
25. Roth SH, Bennett RE. Nonsteroidal anti-inflammatory drug gastropathy: recognition and response. Arch Intern Med. 1987;147:2093-2100.
26. Roth SH, Bennett RE, Mitchell CS, Hartman RJ. Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Arch Intern Med. 1987;147:1798-1801.
27. Lanza F, Peace K, Gustitus L, Rack MF, Dickson B. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration. Am J Gastroenterol. 1988;83:143-146.
28. Stalnikowicz R, Goldin E, Fich A, et al. Indomethacin-induced gastroduodenal damage is not affected by cotreatment with ranitidine. J Clin Gastroenterol. 1989;11:178-182.
29. Stern AI, Ward F, Sievert W. Lack of gastric mucosal protection by sucralfate during long-term aspirin ingestion by humans. Am J Med. 1989;86(suppl 6A):66-69.
30. McCarthy DM. Nonsteroidal antiinflammatory drug-induced ulcers: management by traditional therapies. Gastroenterology. 1989;96:662-674.
31. Graham DY. Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy. Gastroenterology. 1989;96: 675-681.
32. Jiranek GC, Kimmey MB, Saunders DR, Willson RA, Shanahan W, Silverstein FE. Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study. Gastroenterology. 1989;96:656-661.
33. Graham DY, Agrawal NM, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet. 1988;2:1277-1280.
34. Hawkey CJ, Rampton DS. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? Gastroenterology. 1985;89:1162-1188.
35. Lanza FL, Fakouhi D, Rubin A, et al. A double-blind placebo-controlled comparison of the efficacy and safety of 50,100, and 200 μg of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms. Am J Gastroenterol. 1989;84:633-636.
36. Nicholson PA. A multicenter international controlled comparison of two dosage regimens of misoprostol and cimetidine in the treatment of duodenal ulcer in out-patients. Dig Dis Sci. 1985;30:171S-177S.
37. Rachmilewicz D, Chapman JW, Nicholson PA. A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcers in outpatients. Dig Dis Sci. 1986;31: 75S-80S.